From: Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
 | All | Female | Male | p-value |
---|---|---|---|---|
n (%) | 357 | 122 (34.2) | 235 (65.8) | Â |
Age in year, mean (SD) | 66.5 (10.6) | 66.1 (11.1) | 66.7 (10.0) | 0.580 |
FEV1%pred., mean (SD) | 55.0 (18.5) | 58.0 (19.4) | 53.4 (17.9) | 0.067 |
Smoking status, n (%) | ||||
 Current smoker | 126 (35.3) | 43 (35.3) | 83 (35.3) | 0.982 |
 Former smoker | 205 (57.4) | 67 (54.9) | 138 (58.7) | 0.471 |
 Never smoker | 14 (3.9) | 8 (6.5) | 6 (2.6) | 0.065 |
 No information | 12 (3.4) | 4 (3.3) | 8 (3.4) |  |
Inhaled Therapy, n (%) | ||||
 LAMA only | 10 (2.8) | 3 (2.5) | 7 (3.0) | 0.777 |
 LABA only | 3 (0.8) | 2 (1.6) | 1 (0.4) | 0.233 |
 LABA + ICS | 64 (17.9) | 34 (27.9) | 30 (12.8) | <  0.001 |
 LAMA + LABA + ICS | 275 (77.0) | 80 (65.6) | 195 (83.0) | <  0.001 |
 LABA + LAMA | 5 (1.4) | 3 (2.5) | 2 (0.9) | 0.952 |
LTOT, n (%) | 60 (17.0) | 26 (21.5) | 34 (14.7) | 0.101 |